Quest for the right Drug

|
עמוד הבית / טרנקסמיק-מדו להזרקה / מידע מעלון לרופא

טרנקסמיק-מדו להזרקה TRANEXAMIC - MEDO INJECTION (TRANEXAMIC ACID)

תרופה במרשם תרופה בסל נרקוטיקה ציטוטוקסיקה

צורת מתן:

תוך-ורידי : I.V

צורת מינון:

תמיסה להזרקה : SOLUTION FOR INJECTION

Adverse reactions : תופעות לוואי

4.8. Undesirable effects
The adverse reactions reported from clinical studies and post-marketing experience are listed below according to system organ class.
Tabulated list of adverse reactions
Adverse reactions reported are presented in the table below. Adverse reactions are listed according to MedDRA primary system organ class. Within each system organ class, adverse reactions are ranked by frequency. Within each frequency grouping, adverse reactions are presented in the order of decreasing seriousness.
Frequencies were defined as follows: Common (>1/100 to <1/10); uncommon (>1/1,000 to <1/100), not know (cannot be estimated from the available data).


MedDRA                           Frequency                          Undesirable Effects System Organ Class
Immune system disorders                   Not known                 - Hypersensitivity reactions including anaphylaxis
Nervous system disorders                  Not known                 - Dizziness, Convulsions particularly in case of misuse (refer to sections
4.3 and 4.4)
Eye disorders                      Not known                 - Visual disturbances including impaired colour vision
Vascular disorders                    Not known                 - Malaise with hypotension, with or without loss of consciousness
(generally following a too fast
Intravenous injection, exceptionally after oral administration)
- Arterial or venous thrombosis at any sites
Gastrointestinal disorders                 Common                   - Diarrhoea - Vomiting
- Nausea
Skin and subcutaneous tissues       Uncommon                             - Dermatitis allergic disorders

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorization of the medicinal product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product.
Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form https://sideeffects.health.gov.il/


שימוש לפי פנקס קופ''ח כללית 1994 לא צוין
תאריך הכללה מקורי בסל לא צוין
הגבלות לא צוין

בעל רישום

A.L. MEDI-MARKET LTD.

רישום

162 52 35399 00

מחיר

0 ₪

מידע נוסף

עלון מידע לרופא

04.04.21 - עלון לרופא 18.10.22 - עלון לרופא

עלון מידע לצרכן

לתרופה במאגר משרד הבריאות

טרנקסמיק-מדו להזרקה

קישורים נוספים

RxList WebMD Drugs.com